Mahendra S. Rao
Affiliations: | Invitrogen, Merelbeke, Vlaanderen, Belgium |
Area:
Stem cellsGoogle:
"Mahendra Rao"Mean distance: 13.27 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentorPaul H. Patterson | grad student | Caltech | |
Story C. Landis | post-doc | Case Western | |
David J. Anderson | research scientist | Caltech |
Children
Sign in to add traineeJeffrey Christian Lee | grad student | 2002 | University of Utah |
Yuanyuan Wu | grad student | 2002 | University of Utah |
Jingli Cai | grad student | 2003 | University of Utah |
Ying Liu | grad student | 2003 | University of Utah |
Catherine M. Schwartz | grad student | 2004-2006 | Invitrogen |
Collaborators
Sign in to add collaboratorItzhak Fischer | collaborator | ||
Gerald J. Spangrude | collaborator | 2002- | University of Utah (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sun C, Serra C, Kalicharan BH, et al. (2024) Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy. Cells. 13 |
Brown KS, Rao MS, Brown HL. (2019) The Future State of Newborn Stem Cell Banking. Journal of Clinical Medicine. 8 |
Mukherjee O, Acharya S, Rao M. (2019) Making NSC and Neurons from Patient-Derived Tissue Samples. Methods in Molecular Biology (Clifton, N.J.). 1919: 9-24 |
Shcheglovitov A, Rao M, Yoo A. (2018) Special Issue on Stem cell and Tissue Engineering in Development, Disease and Repair. Developmental Dynamics : An Official Publication of the American Association of Anatomists |
Rao MS, Pei Y, Garcia TY, et al. (2018) Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols. Cytotherapy |
Iyer S, Bhatia P, Rao M, et al. (2018) Developing two reference control samples for the Indian population. Stem Cell Research. 30: 38-42 |
Shafa M, Yang F, Fellner T, et al. (2018) Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers. Frontiers in Medicine. 5: 69 |
Chen G, Rao M. (2017) Derivation of Human-Induced Pluripotent Stem Cells in Chemically Defined Medium. Methods in Molecular Biology (Clifton, N.J.). 1590: 131-137 |
Lin Y, Linask KL, Mallon B, et al. (2017) Heparin Promotes Cardiac Differentiation of Human Pluripotent Stem Cells in Chemically Defined Albumin-Free Medium, Enabling Consistent Manufacture of Cardiomyocytes. Stem Cells Translational Medicine. 6: 527-538 |
Zeng X, Pei Y, Cifuentes H, et al. (2017) Making multiple therapeutic cell products from a cGMP-compliant iPSC line Cytotherapy. 19: e22 |